Pharma stocks are gaining momentum as obesity drugs, oncology therapies and biotech innovation boost investor optimism.

Jyong Biotech Ltd. (Nasdaq: MENS) (the 'Company” or 'Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...

Completed enrollment in first cohort of Phase 1b challenge study evaluating CDI-988 as a preventive and as a treatment for norovirus infection, began enrollment in prevention and treatment ...

Chinese pharmaceutical enterprises are moving from exporting single products to engaging in systematic and ecological collaborations as part of their global strategy, executives from the United States ...

Renewed pharma interest in GPCR biology and radioligand therapies is drawing attention to functional peptide screening ...

Marty Makary's departure, amid reports that Trump planned to fire him, is the result of an 'inherited crisis' and 'shifting ...

The new financing will be used to scale the company's drug development efforts, grow its research programs and expand its ...

INNOVOTEX Inc., a pharmaceutical company advancing a new class of tumor-selective oncology therapeutics known as Macrocycle Drug Conjugates (MDCs), today announced the appointment of Dr. Krystle ...

By spearheading AI-driven drug discovery, Lai and his company aim to make life-saving treatments more accessible. Lai is the ...

Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, announces that it has been named a winner of the 2026 GHP Magazine ...

Manufacturing operations divestiture sharpens focus on core capabilities in novel drug discovery and developmentManufacturing divestiture and expanded monetization of ZYNYZ royalty anticipated to prov ...

Drug discovery remains unevenly distributed worldwide. While many countries in the Global South carry a high burden of infectious, neglected, inflammatory, ...